8-K
Current Report
Werewolf Therapeutics, Inc. Filed Acc 0001193125-26-360059
Material agreement · Unregistered share sale · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading d102535d8k.htm…